Epithelial-mesenchymal transition in keloid tissue

Article information

Arch Plast Surg. 2018;45(6):600-601
Publication date (electronic) : 2018 November 15
doi : https://doi.org/10.5999/aps.2017.01214
1Department of Plastic and Reconstructive Surgery, Institute for Human Tissue Restoration, Yonsei University College of Medicine, Seoul, Korea
2Department of Dermatology and Cutaneous Biology Research Institute, Yonsei University College of Medicine, Seoul, Korea
3Department of Bioengineering, Hanyang University College of Engineering, Seoul, Korea
Correspondence: Won Jai Lee Department of Plastic and Reconstructive Surgery, Institute for Human Tissue Restoration, Severance Hospital, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul 03722, Korea Tel: +82-2-2228-2210, Fax: +82-2-393-6947 E-mail: pswjlee@yuhs.ac
Received 2017 July 25; Revised 2018 March 3; Accepted 2018 March 15.

Fibroblasts at the wound site are recognized as the primary drivers of scar formation. They differentiate into myofibroblasts, the key mediators of fibrosis, which are responsible for collagen deposition and wound contraction. Repair processes cease when epithelialization is completed in normal wounds, whereas in keloid wounds, they may continue and result in excessive accumulation of unorganized extracellular matrix, forming problematic scars.

In addition to resident mesenchymal cells, fibroblasts and myofibroblasts are thought to be derived from multiple sources, including epithelial-mesenchymal transition (EMT) [1]. During this process, epithelial cells experience intercellular and intracellular changes, including dissociation of junctional complexes, loss of apical-basolateral polarity, and repression of epithelial markers. As a result, epithelial cells lose many of their properties and take on characteristics of mesenchymal cells.

To investigate this process, an immunofluorescence assay using both epithelial and mesenchymal markers was performed using keloid tissues obtained from the anterior chest wall of a 70-year-old male patient (Fig. 1). After fixation, cells were incubated with primary antibodies against E-cadherin and vimentin (Abcam, Cambridge, UK), and subsequently labelled with fluorescently-tagged secondary antibodies. Counterstaining with 4’,6-diamidino-2-phenylindole (DAPI) (VECTOR Laboratories, Burlingame, CA, USA) was also performed.

Fig. 1.

Patient with a keloid. A 70-year-old male with a keloid on the post-sternotomy area suffered from itchiness, pain, and skin tightening. The keloid was surgically excised intralesionally.

Cells were visualized using an LSM 700 Carl Zeiss confocal microscope (Carl Zeiss MicroImaging, Thornwood, NY, USA). E-cadherin and vimentin expression were simultaneously observed at the dermo-epidermal junction in keloid tissue, indicating the occurrence of EMT (Fig. 2).

Fig. 2.

Epithelial-mesenchymal transition (EMT) characteristics in keloid tissue. (A) Expression of the epithelial marker E-cadherin (green) and (B) the mesenchymal marker vimentin (red) was observed via immunofluorescence. (C) DAPI counterstain of nuclei (blue). (D) Co-expression of E-cadherin and vimentin at the dermo-epidermal junction was observed, indicating the occurrence of the EMT process (A-D, magnification ×630).

Although further investigations with additional keloid specimens are needed, we hope that our study yields some insight into the mechanisms of keloid formation.

Notes

No potential conflict of interest relevant to this article was reported.

Ethical approval

The study was approved by the Institutional Review Board of Yonsei University Medical Center (IRB No. 4-2017-0259) and performed in accordance with the principles of the Declaration of Helsinki. Written informed consent was obtained.

Patient consent

The patient provided written informed consent for the publication and the use of his image.

References

1. Wynn TA. Cellular and molecular mechanisms of fibrosis. J Pathol 2008;214:199–210.

Article information Continued

Fig. 1.

Patient with a keloid. A 70-year-old male with a keloid on the post-sternotomy area suffered from itchiness, pain, and skin tightening. The keloid was surgically excised intralesionally.

Fig. 2.

Epithelial-mesenchymal transition (EMT) characteristics in keloid tissue. (A) Expression of the epithelial marker E-cadherin (green) and (B) the mesenchymal marker vimentin (red) was observed via immunofluorescence. (C) DAPI counterstain of nuclei (blue). (D) Co-expression of E-cadherin and vimentin at the dermo-epidermal junction was observed, indicating the occurrence of the EMT process (A-D, magnification ×630).